Author: Michael

A global analysis forecasts the longevity market’s revenue to exceed US$740 billion in 2026 with sustained growth through to 2036. The research highlights a structural shift from consumer wellness offerings to healthcare‑oriented solutions supported by insurers, employers, health systems and pharmaceutical firms. This trend is creating demand for integrated platforms that support early risk detection, preventive care and ongoing clinical engagement. Technological advances in artificial intelligence, genomics and regenerative medicine are identified as key forces shaping the longevity market’s trajectory. AI‑enabled platforms are being used to analyse complex biological and longitudinal data to speed early‑stage discovery and prioritise therapeutic targets.…

Read More